O. Avdeyeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
O. Avdeyeva has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Zh.D. Semydotska
Kharkiv National Medical University
2 shared publications I. Chernyakova
Kharkiv National Medical University
1 shared publication- I.A. Chernyakova
Kharkiv National Medical University, Kharkiv, Ukraine
1 shared publication - N.S. Tryfonova
Kharkiv National Medical University, Kharkiv, Ukraine
1 shared publication - Olena Pionova
Kharkiv National Medical University, Kharkiv, Ukraine
1 shared publication - T.YU. Khimich
Kharkiv Institute of Medicine and Biomedical Sciences
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Kharkiv National Medical University in Inter Collegas
- Vol. 1 (13)
Transdisciplinary approaches to the prevention and treatment of medication-resistant hypertension in young people (literature review)
Background. Medication-resistant arterial hypertension in people aged 10–30 years is clinically important because persistent blood pressure elevation is associated with early target-organ damage and long-term cardiovascular risk. Aim. To examine current approaches to the prevention and treatment of medication-resistant hypertension in people aged 10–30 years, including non-pharmacological and pharmacological strategies and transdisciplinary models of care. Materials and Methods. This article presents a narrative review of the scientific literature of the past 10 years retrieved from the PubMed, Scopus and Web of Science databases. Inclusion criteria were English-language peer-reviewed clinical and cohort studies, randomized controlled trials, clinical guidelines, systematic reviews, and directly relevant narrative reviews addressing people aged 10–30 years; adult-only studies without applicability to this age range, conference abstracts without full text, and non-peer-reviewed material were excluded. The study was conducted as a private initiative of the authors, without grant support or state registration of the research topic. Research Ethics. The review analyzed only published data whose authors declared compliance with ethical standards. Results. Resistant hypertension was treated as an age-specific phenotype: adult criteria require at least three drugs of different classes, including a diuretic, at maximally tolerated doses with confirmation of uncontrolled values outside the clinic, whereas pediatric criteria are percentile-based. Pseudoresistance caused by non-adherence, the white-coat effect, and measurement error has to be excluded first. Obesity, short sleep, high sodium intake, energy-drink consumption, marked prematurity, and very low birth weight are identifiable contributors, while renal, renovascular and endocrine secondary causes require targeted evaluation. Lifestyle modification and age-adapted pharmacotherapy are supported, but evidence or direct intervention in this age range remains limited. Conclusions. The aim was achieved: transdisciplinary approaches to the prevention, diagnosis, and treatment of medication-resistant arterial hypertension among people aged 10–30 years were identified and systematized. Diagnostic verification precedes the diagnosis of true resistance; secondary and pseudoresistant forms require targeted evaluation; transdisciplinary care is justified as an organizational framework, although comparative studies are lacking. Keywords: cardiology, juvenile hypertension, pediatric blood pressure, renin-angiotensin-aldosterone system.
- 31 March 2026
- Published by Kharkiv National Medical University in Inter Collegas
- Vol. 1 (13)
Open AccessTransdisciplinary approaches to the prevention and treatment of medication-resistant hypertension in young people (literature review)
Background. Medication-resistant arterial hypertension in people aged 10–30 years is clinically important because persistent blood pressure elevation is associated with early target-organ damage and long-term cardiovascular risk. Aim. To examine current approaches to the prevention and treatment of medication-resistant hypertension in people aged 10–30 years, including non-pharmacological and pharmacological strategies and transdisciplinary models of care. Materials and Methods. This article presents a narrative review of the scientific literature of the past 10 years retrieved from the PubMed, Scopus and Web of Science databases. Inclusion criteria were English-language peer-reviewed clinical and cohort studies, randomized controlled trials, clinical guidelines, systematic reviews, and directly relevant narrative reviews addressing people aged 10–30 years; adult-only studies without applicability to this age range, conference abstracts without full text, and non-peer-reviewed material were excluded. The study was conducted as a private initiative of the authors, without grant support or state registration of the research topic. Research Ethics. The review analyzed only published data whose authors declared compliance with ethical standards. Results. Resistant hypertension was treated as an age-specific phenotype: adult criteria require at least three drugs of different classes, including a diuretic, at maximally tolerated doses with confirmation of uncontrolled values outside the clinic, whereas pediatric criteria are percentile-based. Pseudoresistance caused by non-adherence, the white-coat effect, and measurement error has to be excluded first. Obesity, short sleep, high sodium intake, energy-drink consumption, marked prematurity, and very low birth weight are identifiable contributors, while renal, renovascular and endocrine secondary causes require targeted evaluation. Lifestyle modification and age-adapted pharmacotherapy are supported, but evidence or direct intervention in this age range remains limited. Conclusions. The aim was achieved: transdisciplinary approaches to the prevention, diagnosis, and treatment of medication-resistant arterial hypertension among people aged 10–30 years were identified and systematized. Diagnostic verification precedes the diagnosis of true resistance; secondary and pseudoresistant forms require targeted evaluation; transdisciplinary care is justified as an organizational framework, although comparative studies are lacking. Keywords: cardiology, juvenile hypertension, pediatric blood pressure, renin-angiotensin-aldosterone system.
- Open Access
- 14 November 2019
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 1(65),p. 48-57
Kidneys and microbiota
The review article analyzes the results of studies of the bi-directional relationship of the intestinal microbiota and kidneys, the so-called colorenal interactive axis of interaction. The intestinal microbiota is considered as a kind of organ that influences the brain, cardiovascular and immune systems, as well as the kidneys of the "host". Short-chain fatty acids (SCFA) formed in the colon as the result of microbial metabolism from plant components of dietary fiber and acting as ligands for the olfactory receptor, paired G-proteins in the kidneys are recognized as the markers of this symbiosis. With the help of modern omix technologies, the development of dysbiosis taking into account patients with chronic kidney disease (CKD) has been proved, which leads to the accumulation of precursors of uremic toxins, a decrease in the production of SCFA, which have nephroprotective properties and play a key role in energy homeostasis. Changes in the composition of the intestinal microbiota in CKD, an increase in the content of uremic toxins in the intestinal lumen contribute to the appearance of the “leaky” intestinal barrier syndrome, the movement of bacteria from the intestine into the general circulation, the development of systemic inflammation, oxidative stress, comorbidity, the progression of CKD, and an increase in mortality. Diets with restriction of protein and potassium quotas, violation of nutritional status lead to the development of dysbiosis in CKD. A decrease in the diet of vegetables and fruit causes the expansion of bacteria producing uricase and urease, which are enzymes in the formation of uremic toxins and reduce the number and variety of bacteria producing short-chain fatty acids. Potential targeted effects on the axis of “intestinal microbiota - chronic kidney disease” are being discussed: the use of a diet enriched in plant fibers, heat-treated, then chilled potatoes and rice as prebiotics (sources of resistant starch), nuts, plant seeds, and pro-, pre-, synbiotics, fecal transplantation. Most of the proposed interventions in the structure and functions of the microbiota are not dangerous, side effects are minimal.
- 14 November 2019
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 1(65),p. 48-57
Open AccessKidneys and microbiota
The review article analyzes the results of studies of the bi-directional relationship of the intestinal microbiota and kidneys, the so-called colorenal interactive axis of interaction. The intestinal microbiota is considered as a kind of organ that influences the brain, cardiovascular and immune systems, as well as the kidneys of the "host". Short-chain fatty acids (SCFA) formed in the colon as the result of microbial metabolism from plant components of dietary fiber and acting as ligands for the olfactory receptor, paired G-proteins in the kidneys are recognized as the markers of this symbiosis. With the help of modern omix technologies, the development of dysbiosis taking into account patients with chronic kidney disease (CKD) has been proved, which leads to the accumulation of precursors of uremic toxins, a decrease in the production of SCFA, which have nephroprotective properties and play a key role in energy homeostasis. Changes in the composition of the intestinal microbiota in CKD, an increase in the content of uremic toxins in the intestinal lumen contribute to the appearance of the “leaky” intestinal barrier syndrome, the movement of bacteria from the intestine into the general circulation, the development of systemic inflammation, oxidative stress, comorbidity, the progression of CKD, and an increase in mortality. Diets with restriction of protein and potassium quotas, violation of nutritional status lead to the development of dysbiosis in CKD. A decrease in the diet of vegetables and fruit causes the expansion of bacteria producing uricase and urease, which are enzymes in the formation of uremic toxins and reduce the number and variety of bacteria producing short-chain fatty acids. Potential targeted effects on the axis of “intestinal microbiota - chronic kidney disease” are being discussed: the use of a diet enriched in plant fibers, heat-treated, then chilled potatoes and rice as prebiotics (sources of resistant starch), nuts, plant seeds, and pro-, pre-, synbiotics, fecal transplantation. Most of the proposed interventions in the structure and functions of the microbiota are not dangerous, side effects are minimal.
- Open Access
- 22 March 2019
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- No. 1.96,p. 62-68
Особенности липидного профиля и кардиогемодинамики при хронической обструктивной болезни легких и коморбидности
Актуальность. Хроническая обструктивная болезнь легких является классическим примером коморбидного состояния, характеризующегося сочетанием ишемической болезни сердца, артериальной гипертензии и метаболического синдрома. Целью исследования было изучение особенностей взаимосвязи между параметрами липидного спектра и эхокардиографии у пациентов с хронической обструктивной болезнью легких, ишемической болезнью сердца и артериальной гипертензией. Материалы и методы. Обследовано 35 пациентов с хронической обструктивной болезнью легких и сопутствующей патологией (57,14 % мужчин, 42,86 % женщин). Средний возраст составил 57,0 года, средняя продолжительность заболевания — 10,02 [5,0–15,0] года. У 23 пациентов выявлена коморбидность с ишемической болезнью сердца и артериальной гипертензией, у 11 пациентов был сахарный диабет 2-го типа, у 8 — ишемическая болезнь сердца (кардиосклероз, стенокардия), у 4 — артериальная гипертензия. Результаты. Пациенты были разделены на 3 группы: B (n = 12), C (n = 14), D (n = 9). В группе B выявлены 3 положительные достоверные корреляции диаметра аорты с уровнями общего холестерина, липопротеинов низкой и очень низкой плотности. В группе С имеются 2 корреляции с давлением в легочной артерии: положительная — содержания липопротеинов низкой плотности и отрицательная — липопротеинов высокой плотности, а также отрицательная связь между уровнем триглицеридов и диастолическим объемом левого желудочка. В группе D число корреляций увеличивается до 6: появляются корреляции содержания липопротеинов низкой плотности с параметрами правого предсердия и желудочка, а также левого желудочка. Было отмечено, что при коморбидности с ишемической болезнью сердца количество корреляций увеличивается в два раза. Выводы. Прогрессирование хронической обструктивной болезни легких и ее сочетание с сопутствующими состояниями приводит к увеличению количества корреляционных связей между липидным спектром и показателями эхокардиографии, особенно при коморбидности с ишемической болезнью сердца.
- 22 March 2019
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- No. 1.96,p. 62-68
Open AccessОсобенности липидного профиля и кардиогемодинамики при хронической обструктивной болезни легких и коморбидности
Актуальность. Хроническая обструктивная болезнь легких является классическим примером коморбидного состояния, характеризующегося сочетанием ишемической болезни сердца, артериальной гипертензии и метаболического синдрома. Целью исследования было изучение особенностей взаимосвязи между параметрами липидного спектра и эхокардиографии у пациентов с хронической обструктивной болезнью легких, ишемической болезнью сердца и артериальной гипертензией. Материалы и методы. Обследовано 35 пациентов с хронической обструктивной болезнью легких и сопутствующей патологией (57,14 % мужчин, 42,86 % женщин). Средний возраст составил 57,0 года, средняя продолжительность заболевания — 10,02 [5,0–15,0] года. У 23 пациентов выявлена коморбидность с ишемической болезнью сердца и артериальной гипертензией, у 11 пациентов был сахарный диабет 2-го типа, у 8 — ишемическая болезнь сердца (кардиосклероз, стенокардия), у 4 — артериальная гипертензия. Результаты. Пациенты были разделены на 3 группы: B (n = 12), C (n = 14), D (n = 9). В группе B выявлены 3 положительные достоверные корреляции диаметра аорты с уровнями общего холестерина, липопротеинов низкой и очень низкой плотности. В группе С имеются 2 корреляции с давлением в легочной артерии: положительная — содержания липопротеинов низкой плотности и отрицательная — липопротеинов высокой плотности, а также отрицательная связь между уровнем триглицеридов и диастолическим объемом левого желудочка. В группе D число корреляций увеличивается до 6: появляются корреляции содержания липопротеинов низкой плотности с параметрами правого предсердия и желудочка, а также левого желудочка. Было отмечено, что при коморбидности с ишемической болезнью сердца количество корреляций увеличивается в два раза. Выводы. Прогрессирование хронической обструктивной болезни легких и ее сочетание с сопутствующими состояниями приводит к увеличению количества корреляционных связей между липидным спектром и показателями эхокардиографии, особенно при коморбидности с ишемической болезнью сердца.